Detalhe da pesquisa
1.
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
Br J Haematol
; 198(6): 988-993, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608261